NCT06000176

Brief Summary

This work aims to study the peripapillary and macular microvascular changes in primary open angle and primary angle closure glaucoma using Optical Coherence Tomography Angiography (OCTA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 5, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2023

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

August 12, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 21, 2023

Completed
Last Updated

August 21, 2023

Status Verified

August 1, 2023

Enrollment Period

1.3 years

First QC Date

August 12, 2023

Last Update Submit

August 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • OCTA macula and ONH

    macular 6\*6,3\*3 and peripapillary vessel density

    We will recruit patient that include the inclusion criteria from april2022 to july 2023

Study Arms (1)

interventional details : diagnostic test OCTA macula and ONH

interventional details : diagnostic test OCTA macula and ONH in the 3 groups

Device: Optical coherence tomography angiography

Interventions

diagnostic test OCTA macula and ONH

interventional details : diagnostic test OCTA macula and ONH

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with primary open angle ,primary angle closure glaucoma and control patients

You may qualify if:

  • Age ≥ 18 years old.
  • Fulfilling Diagnostic criteria of PACG patients :occluded angle by gonioscopy in which \> 180˚ of trabecular meshwork cannot be seen , IOP\>21, Optic disc and RNFL damage due to glaucoma
  • Diagnosed POAG patient: open anterior chamber angle ,IOP\>21 ,Optic disc and RNFL damage due to glaucoma
  • Healthy patient: normal anterior chamber, open angle and normal fundus.

You may not qualify if:

  • History of other causes of optic neuropathy.
  • History of systemic diseases. (HTN, DM, Cardiac).
  • Previous ocular surgeries or Laser iridotomy.
  • Poor quality of OCTA image less than 4/10.
  • Refractive errors \> 6 diopters sphere, \>3 diopter cylinder
  • Poor cooperation or fixation with the OCTA examination.
  • Secondary causes of glaucoma
  • Media opacity that interfere with quality of image (dense cataract,corneal opacity,…)
  • Previous acute attack of ACG

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Athar Mohamed Mohamed Makhlouf

Al Fayyum, Egypt

Location

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor Of Ophthalmology

Study Record Dates

First Submitted

August 12, 2023

First Posted

August 21, 2023

Study Start

April 5, 2022

Primary Completion

July 20, 2023

Study Completion

July 20, 2023

Last Updated

August 21, 2023

Record last verified: 2023-08

Locations